Health-care companies rose as traders rotated back into sectors that had led the stock market before the recent correction.
Some areas of health care, including biotech, were lumped in with the "growth" sectors that led the stock-market surge in 2021 and sold off heavily earlier in 2022.
Eagle Pharmaceuticals shares rose sharply after the company agreed to buy Acacia Pharma Group for about $101.2 million, gaining access to two treatments already on the market.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-28-22 1737ET
